Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.07 USD | -2.73% | -0.93% | -13.71% |
09/05 | Transcript : Akebia Therapeutics, Inc., Q1 2024 Earnings Call, May 09, 2024 | |
09/05 | Earnings Flash (AKBA) AKEBIA THERAPEUTICS Reports Q1 Revenue $32.6M | MT |
Sales 2024 * | 173M 14.4B | Sales 2025 * | 159M 13.3B | Capitalization | 224M 18.71B |
---|---|---|---|---|---|
Net income 2024 * | -64M -5.34B | Net income 2025 * | -73M -6.09B | EV / Sales 2024 * | 1.3 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 1.41 x |
P/E ratio 2024 * |
-4.12
x | P/E ratio 2025 * |
-3.28
x | Employees | 167 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 91.79% |
Latest transcript on Akebia Therapeutics, Inc.
1 day | -2.73% | ||
1 week | -0.93% | ||
Current month | -4.46% | ||
1 month | -28.19% | ||
3 months | -28.19% | ||
6 months | -7.76% | ||
Current year | -13.71% |
Managers | Title | Age | Since |
---|---|---|---|
John Butler
CEO | Chief Executive Officer | 59 | 01/13/01 |
Tracey Vetterick
ADM | Chief Administrative Officer | - | 01/22/01 |
Michel Dahan
COO | Chief Operating Officer | 45 | 01/13/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Rogers
BRD | Director/Board Member | 64 | 12/18/12 |
Adrian Adams
CHM | Chairman | 73 | 12/18/12 |
LeAnne Zumwalt
BRD | Director/Board Member | 65 | 16/21/16 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
06/24/06 | 1.07 | -2.73% | 2,236,485 |
05/24/05 | 1.1 | -2.65% | 1,362,319 |
04/24/04 | 1.13 | -0.88% | 2,570,459 |
03/24/03 | 1.14 | +1.79% | 2,008,056 |
31/24/31 | 1.12 | +3.70% | 2,114,042 |
Delayed Quote Nasdaq, June 07, 2024 at 01:30 am IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.71% | 224M | |
+19.33% | 125B | |
+13.95% | 108B | |
-3.53% | 24.57B | |
+2.71% | 22.82B | |
-9.95% | 18.19B | |
-41.48% | 16.54B | |
-12.62% | 16.5B | |
+0.99% | 13.39B | |
+21.79% | 11.1B |
- Stock Market
- Equities
- AKBA Stock